Tender detail
Open-house discount agreements for biologics: Somatropin, 2026–35
Summary
The participating health insurance funds are seeking discount agreements with pharmaceutical companies for the active substance somatropin under an open-house procedure. The agreements use uniform terms, involve no individual negotiations and grant no exclusivity. They may run for up to 24 months from 1 January 2027 and end no later than 31 December 2028, regardless of the signing date; lot details are specified separately.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.